LA
GSK icon

LexAurum Advisors’s GSK GSK Stock Holding History

LexAurum Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,512
Closed -$206K – 217
2019
Q4 		$206K Buy
+3,512
New +$195K 0.1% 190
2019
Q2 		– Sell
-3,968
Closed -$207K – 180
2019
Q1 		$207K Sell
3,968
-2,260
-36% -$113K 0.14% 151
2018
Q4 		$297K Buy
6,228
+176
+3% +$8.67K 0.23% 100
2018
Q3 		$304K Sell
6,052
-336
-5% -$17.1K 0.21% 105
2018
Q2 		$322K Sell
6,388
-80
-1% -$4.03K 0.29% 90
2018
Q1 		$316K Buy
6,468
+904
+16% +$42.1K 0.27% 97
2017
Q4 		$261K Buy
+5,564
New +$257K 0.24% 111

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

LexAurum Advisors's GSK Position: Q1 2020 in Review

LexAurum Advisors sold out of GSK (GSK) in Q1 2020, closing a stake of 3,512 shares — an estimated $206K sold.

LexAurum Advisors first reported a position in GSK in Q4 2017 and held it in 7 quarters. The position peaked at $322K in Q2 2018. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • LexAurum Advisors reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • LexAurum Advisors sold 3,512 GSK shares in Q1 2020, an estimated $206K.
  • LexAurum Advisors first reported a position in GSK in Q4 2017 and held it in 7 quarters.
  • LexAurum Advisors's GSK position peaked at $322K in Q2 2018.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on LexAurum Advisors's 13F filing for Q1 2020, filed 22 Apr 2020.